Literature DB >> 24447070

Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Nicole Trager1, Amena Smith, Gerald Wallace Iv, Mitsuyoshi Azuma, Jun Inoue, Craig Beeson, Azizul Haque, Naren L Banik.   

Abstract

Multiple sclerosis (MS) pathology is marked by the massive infiltration of myelin-specific T cells into the CNS. Hallmarks of T helper (Th) cells during active disease are pro-inflammatory Th1/Th17 cells that predominate over immunoregulatory Th2/Treg cells. Neurodegeneration, a major factor in progressive MS, is often overlooked when considering drug prescription. Here, we show that oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two pronged effect via anti-inflammation and protection against neurodegeneration. We also show that SNJ-1945 treatment down-regulates Th1/Th17 inflammatory responses, and promotes regulatory T cells (Tregs) and myeloid-derived suppressor cells in vivo, which are known to have the capacity to suppress helper as well as cytotoxic T cell functions. Through analysis of spinal cord samples, we show a reduction in calpain expression, decreased infiltration of inflammatory cells, and signs of inhibition of neurodegeneration. We also show a marked reduction in neuronal cell death in spinal cord (SC) sections. These results suggest that calpain inhibition attenuates experimental autoimmune encephalomyelitis pathology by reducing both inflammation and neurodegeneration, and could be used in clinical settings to augment the efficacy of standard immunomodulatory agents used to treat MS. Multiple sclerosis (MS) pathology is marked by inflammation and infiltration of myelin-specific T cells into the central nervous system. Inflammation leads to neurodegeneration in progressive MS which also leads to epitope spreading, feedback looping to more inflammation. Calpain can play a role in both arms of the disease. Here, oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two-pronged effect via anti-inflammation and protection against neurodegeneration.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  EAE; calpain; inflammation; multiple sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24447070      PMCID: PMC4107076          DOI: 10.1111/jnc.12659

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  54 in total

Review 1.  Regulation of STAT signalling by proteolytic processing.

Authors:  Lisa Hendry; Susan John
Journal:  Eur J Biochem       Date:  2004-12

2.  A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis.

Authors:  Getaw Worku Hassen; Jason Feliberti; Leo Kesner; Alfred Stracher; Foroozan Mokhtarian
Journal:  J Neuroimmunol       Date:  2006-09-26       Impact factor: 3.478

3.  Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4.

Authors:  Péter Medveczky; József Antal; András Patthy; Katalin Kékesi; Gábor Juhász; László Szilágyi; László Gráf
Journal:  FEBS Lett       Date:  2005-12-29       Impact factor: 4.124

4.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

5.  Retinal penetration of calpain inhibitors in rats after oral administration.

Authors:  Yoshihisa Shirasaki; Masazumi Yamaguchi; Hiroyuki Miyashita
Journal:  J Ocul Pharmacol Ther       Date:  2006-12       Impact factor: 2.671

6.  Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester.

Authors:  T Oka; R D Walkup; Y Tamada; E Nakajima; A Tochigi; T R Shearer; M Azuma
Journal:  Neuroscience       Date:  2006-07-14       Impact factor: 3.590

Review 7.  Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.

Authors:  Ayda Tekok-Kilic; Ralph H B Benedict; Robert Zivadinov
Journal:  Expert Rev Neurother       Date:  2006-03       Impact factor: 4.618

8.  IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.

Authors:  Mika Nishihara; Hideki Ogura; Naoko Ueda; Mineko Tsuruoka; Chika Kitabayashi; Fumio Tsuji; Hiroyuki Aono; Katsuhiko Ishihara; Eric Huseby; Ulrich A K Betz; Masaaki Murakami; Toshio Hirano
Journal:  Int Immunol       Date:  2007-05-09       Impact factor: 4.823

9.  Sustained elevation of intracellular cGMP causes oxidative stress triggering calpain-mediated apoptosis in photoreceptor degeneration.

Authors:  Ashish K Sharma; Bärbel Rohrer
Journal:  Curr Eye Res       Date:  2007-03       Impact factor: 2.424

10.  Protein co-expression with axonal injury in multiple sclerosis plaques.

Authors:  Maria Diaz-Sanchez; Kelly Williams; Gabriele C DeLuca; Margaret M Esiri
Journal:  Acta Neuropathol       Date:  2006-03-18       Impact factor: 17.088

View more
  17 in total

Review 1.  The signaling symphony: T cell receptor tunes cytokine-mediated T cell differentiation.

Authors:  Weishan Huang; Avery August
Journal:  J Leukoc Biol       Date:  2014-12-18       Impact factor: 4.962

2.  CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.

Authors:  Katherine J Wert; Susanne F Koch; Gabriel Velez; Chun-Wei Hsu; MaryAnn Mahajan; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

Review 3.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

4.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

5.  Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury.

Authors:  Nakul P Thakore; Supriti Samantaray; Sookyoung Park; Kenkichi Nozaki; Joshua A Smith; April Cox; James Krause; Naren L Banik
Journal:  Neurochem Res       Date:  2015-08-20       Impact factor: 3.996

6.  The cell-permeable mitochondrial calcium uniporter inhibitor Ru265 preserves cortical neuron respiration after lethal oxygen glucose deprivation and reduces hypoxic/ischemic brain injury.

Authors:  Robyn J Novorolsky; Matthew Nichols; Jong S Kim; Evgeny V Pavlov; Joshua J Woods; Justin J Wilson; George S Robertson
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-03       Impact factor: 6.200

7.  Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Donald C Shields; April A Cox; Azizul Haque; Naren L Banik
Journal:  Mol Neurobiol       Date:  2015-06-25       Impact factor: 5.590

8.  Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.

Authors:  Azizul Haque; Supriti Samantaray; Varduhi H Knaryan; Mollie Capone; Azim Hossain; Denise Matzelle; Raghavendar Chandran; Donald C Shields; Ariana Q Farrand; Heather A Boger; Naren L Banik
Journal:  Exp Neurol       Date:  2020-04-14       Impact factor: 5.330

9.  Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.

Authors:  Raghavendar Chandran; Mollie Capone; Denise Matzelle; Rachel Polcyn; Elizabeth Kau; Azizul Haque; Naren L Banik
Journal:  Neurochem Res       Date:  2018-10-05       Impact factor: 3.996

Review 10.  Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.

Authors:  Valquiria Bueno; Osvaldo Augusto Sant'Anna; Janet M Lord
Journal:  Age (Dordr)       Date:  2014-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.